Navigation Links
Solon Manufacturing Company Acquires PurFybr Brands; Adds Influenza Virus Diagnostic Swabs to Product Line

NORTH HAVEN, Conn., June 19 /PRNewswire/ -- Solon Manufacturing Co., a leading maker of single use disposable products for the medical, industrial and diagnostic fields, today announced its acquisition of certain assets of PurFybr Inc. The purchase, which specifically includes PurFybr brand rights and trademarks, technology, equipment and inventory, was concluded today.

"We are very excited to add the PurFybr lineup of products to our family of brands," said Ken Shaw, vice president, Solon Manufacturing. "PurFybr has an outstanding reputation for high-quality specialty diagnostic swabs." PurFybr products are the standard worldwide for DNA and influenza virus testing, including H1N1 (swine flu) virus.

PurFybr, which operates manufacturing facilities in Munster, Ind., was one of the first companies to spin polyester, rayon, and calcium alginate onto thin wires. Its products are designed to minimize the risk of irritation and contamination during the collection of specimens for a range of diagnostic testing, including rapid viral tests. Among its products, the company's ultra micro fine wires have been shown to be highly effective in testing for and collecting specimens for sexually transmitted diseases.

Solon fully expects to meet all current and future PurFybr orders and has scheduled the transfer of equipment and inventory during the two-week period PurFybr typically shuts down each year. The PurFybr production facility will close today. Following the move to its state-of-the-art ISO 13485: 2003 FDA-registered facility in Rhinelander, Wisconsin, Solon will perform machine, product and quality process validations prior to resuming production of PurFybr products on July 5th.

"Current PurFybr customers will benefit by having at their disposal the full resources and capabilities of a much larger company," said Shaw. "We look forward to serving them with the same level of quality, choice and value for which Solon is known."

Duane Ehlers, president and owner of privately held PurFybr, will join Solon as a consultant.

About Solon Manufacturing Company

Since 1936 Solon Manufacturing Company has been dedicated to the single use disposable market. We manufacture products for the Medical, Industrial and Diagnostic fields in our state-of-the-art ISO13485: 2003 FDA-registered facility in the United States or from one of our manufacturing partners in Asia. Solon has branded, private label and OEM business worldwide. Solon is a division of privately held Mossberg Corporation and is based in North Haven, Conn.

SOURCE Solon Manufacturing Co.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
2. Middle East Pharma Manufacturing/Biotech is Ready to Boom
3. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
4. Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist
5. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
6. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
7. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
8. Genzyme Begins Major Expansion of Boston Manufacturing Facility
9. SAFC Supports Potent API Conjugate Manufacturing With New St. Louis Production Suite
10. PacificGMP Announces Agreement with BD Biosciences for Cell Banking and cGMP Antibody Manufacturing
11. Thermo Fisher Scientific to Expand Manufacturing Operation for Single-Use Bioprocessing Containers
Post Your Comments:
(Date:6/23/2016)... ... 23, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... Laboratory, has joined STACS DNA as a Field Application Specialist. , “I am ... and COO of STACS DNA. “In further expanding our capacity as a scientific integrator, ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
Breaking Biology Technology:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: ) ... financial services, but it also plays a fundamental part in ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
Breaking Biology News(10 mins):